This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Clapham E, Berg J, Ekman M, Jonsson L.Economic evaluation of agomelatine for major depressive disorder in Sweden. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 176 abstr. PMH22, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Rights and permissions
About this article
Cite this article
Agomelatine is cost effective for major depressive disorder. Pharmacoecon. Outcomes News 579, 6 (2009). https://doi.org/10.2165/00151234-200905790-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905790-00010